Page last updated: 2024-09-03

n-cyano-n'-(2-nitroxyethyl)-3-pyridinecarboximidamide methanesulfonate and Cerebral Infarction, Middle Cerebral Artery

n-cyano-n'-(2-nitroxyethyl)-3-pyridinecarboximidamide methanesulfonate has been researched along with Cerebral Infarction, Middle Cerebral Artery in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Komatsu, K; Kontani, H; Nakamura, Y; Namiki, M; Tanaka, T; Yokoyama, O1

Other Studies

1 other study(ies) available for n-cyano-n'-(2-nitroxyethyl)-3-pyridinecarboximidamide methanesulfonate and Cerebral Infarction, Middle Cerebral Artery

ArticleYear
Effects of adenosine triphosphate dependent potassium channel opener on bladder overactivity in rats with cerebral infarction.
    The Journal of urology, 2002, Volume: 168, Issue:5

    Topics: Animals; Dose-Response Relationship, Drug; Infarction, Middle Cerebral Artery; Injections, Intraventricular; Male; Pons; Potassium Channels; Pyridines; Rats; Rats, Sprague-Dawley; Urinary Bladder, Neurogenic; Urodynamics

2002